Webinar - Beyond Psa: The Exodx Prostate Test As A Precision Genomic Biomarker

Webinar - Beyond PSA: The ExoDx Prostate™ test (EPI) as a Precision Genomic Biomarker

The ExoDx™ Prostate Test: Prostate Cancer and Implications for Value Based Care Part 1

Pairing mpMRI & The ExoDx Prostate Test w/ Dr. David Albala | BackTable Urology Podcast Ep. 112

BackTable Urology Podcast

Beyond PSA: New Tools for the PSA for Early Detection of Prostate Cancer

The ExoDx™ Prostate Test: Prostate Cancer and Implications for Value Based Care Part 2

ExoDx Prostate Test -A Non-Invasive Liquid Biopsy for Prostate Cancer

Beyond the PSA: Emerging Biomarkers for Prostate Cancer Screening

The ExoDx Prostate test for Risk Assessment of high grade prostate cancer (HGPCa)

Diagnostic Biomarkers of Prostate Cancer in 2023 and Beyond

How the ExoDx Prostate Test Impacts Urology Practice in a Real-World Clinical Setting

Exosome Enabled Molecular Analysis: Part 1

Webinar Emerging evidence on PSA in the Diagnosis of Prostate Cancer

European Association of Urology

ExoDx Prostate and ZERO - The End of Prostate Cancer - Facebook Live

ExoDx™ Prostate Test - A Solution to Address Fear of the Prostate Biopsy Decision

Biomarkers: PSA, 4K, or PHI?

Grand Rounds in Urology

Is PSA is the best biomarker to use for prostate cancer detection?

Beyond Diagnosis: PROSTATE CANCER screening with PSA

Roupen Odabashian

When to Biopsy: The Role for PSA and Novel Biomarkers

Grand Rounds in Urology

Diagnosing Prostate Cancer: Moving Beyond PSAs, Gleason Scores and Biopsies Through Advanced Imaging

Stanford Health Care